Multiclass hepatitis C virus resistance to direct acting antivirals in real life interferon-free regimens failures advocates for tailored second-line therapiesVelia Chiara Di Maio, M. Paoloni, C. Magni et al.|Journal of Hepatology|2017Cited by 2
Multiclass HCV resistance to interferon-free direct acting antivirals regimens in real life failures advocates for tailored second-line therapiesVelia Chiara Di Maio, Valeria Pace Palitti, Valeria Cento et al.|Digestive and Liver Disease|2017Cited by 1
The challenge of HCV-retreatment after DAA-failure: real-life experience advocates for cautionValeria Cento, Francesca Ceccherini‐Silberstein, Silvia Barbaliscia et al.|Journal of Hepatology|2017Cited by 1
The challenge of HCV-retreatment after DAA-failure: Italian real-life from VIRONET-C networkValeria Cento, Francesca Ceccherini‐Silberstein, Silvia Barbaliscia et al.|Digestive and Liver Disease|2017Cited by 0
Prevalence and characteristics of resistance associated substitutions in DAA-naive and DAA-failed HCV-3 patients in ItalyVelia Chiara Di Maio, Fausto Baldanti, Silvia Barbaliscia et al.|Digestive and Liver Disease|2017Cited by 0